Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gonal-F plus Menogon versus Menogon alone for ovulation induction in infertile women with polycystic ovary syndrome
IRCT20171030037093N10Phase 2Completed
- Sponsor
- Shahrekord University of Medical Sciences
- Start
- Jun 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label trial of follitropin alfa and luteinizing hormone in polycystic ovary syndrome (PCOS) and female infertility (2 arms), sponsored by Shahrekord University of Medical Sciences. Primary endpoints: Number of oocytes retrieved, Endometrial thickness and 4 more. Started Jun 2019; status: completed.
02
Drugs
follitropin alfaluteinizing hormone
03
Conditions
polycystic ovary syndrome (PCOS)female infertility
Beyond the preview
Go deeper on IRCT20171030037093N10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20171030037093N10.